Saturn V Capital Management as of March 31, 2024
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 21 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals In (CRNX) | 12.4 | $31M | 660k | 46.81 | |
| Argenx Se Sponsored Adr (ARGX) | 10.4 | $26M | 66k | 393.72 | |
| Cytokinetics Com New (CYTK) | 7.4 | $19M | 264k | 70.11 | |
| Kalvista Pharmaceuticals (KALV) | 6.9 | $17M | 1.4M | 11.86 | |
| Merus N V (MRUS) | 6.8 | $17M | 377k | 45.03 | |
| Disc Medicine (IRON) | 6.4 | $16M | 255k | 62.26 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 6.3 | $16M | 103k | 151.17 | |
| Anaptysbio Inc Common (ANAB) | 5.3 | $13M | 586k | 22.52 | |
| Vaxcyte (PCVX) | 5.1 | $13M | 185k | 68.31 | |
| Cogent Biosciences (COGT) | 4.3 | $11M | 1.6M | 6.72 | |
| Amicus Therapeutics (FOLD) | 4.2 | $11M | 898k | 11.78 | |
| BioMarin Pharmaceutical (BMRN) | 4.2 | $10M | 119k | 87.34 | |
| Syndax Pharmaceuticals (SNDX) | 3.8 | $9.5M | 398k | 23.80 | |
| Abivax Sa Sponsored Ads (ABVX) | 3.6 | $8.9M | 623k | 14.30 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 3.3 | $8.2M | 945k | 8.71 | |
| Phathom Pharmaceuticals (PHAT) | 2.1 | $5.3M | 501k | 10.62 | |
| Iteos Therapeutics (ITOS) | 2.1 | $5.3M | 387k | 13.64 | |
| Apellis Pharmaceuticals (APLS) | 1.7 | $4.2M | 72k | 58.78 | |
| Geron Corporation (GERN) | 1.5 | $3.7M | 1.1M | 3.30 | |
| Morphic Hldg (MORF) | 1.2 | $3.0M | 86k | 35.20 | |
| Cabaletta Bio (CABA) | 1.2 | $3.0M | 173k | 17.06 |
